Skip to content

Clarithromycin Impurity 4

Clarithromycin Impurity 4

Product Description
CAT No.
ALN-C040024
CAS No.
NA
Mol. F.
C38H69NO12
Mol. Wt.
732
Stock
Please Inquire
Chemical Name : (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-6-(((3S,4S,6S)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-12-hydroxy-4-(((4R,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
Smiles : O=C([C@H](C)C[C@](OC)(C)[C@H](OC(O[C@@H](C)C[C@@H]1N(C)C)[C@H]1O)[C@@H](C)[C@H](OC2O[C@@H](C)C(O)[C@@](OC)(C)C2)[C@H]3C)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](CC)OC3=O
Inchi : InChI=1S/C38H67NO14/c1-14-26-37(9,45)30(42)21(4)27(40)19(2)16-35(7,46-12)32(51-34-28(41)25(39(10)11)15-20(3)49-34)22(5)29-24(33(44)50-26)17-48-38(53-29)18-36(8,47-13)31(43)23(6)52-38/h19-26,28-32,34,41-43,45H,14-18H2,1-13H3/t19-,20+,21+,22+,23+,24-,25+,26-,28+,29+,30-,31+,32-,34?,35-,36-,37-,38-/m1/s1

Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: method scaling versus re-validation

By Makoni, Pedzisai A.; Chikukwa, Mellisa T. R.; Khamanga, Sandile M. M.; Walker, Roderick B.nFrom Scientia Pharmaceutica (2019), 87(4), 31

Stability indicating Rp-Hplc method development and validation for the simultaneous estimation of gemcitabine and clarithromycin in bulk and pharmaceutical dosage form

By Kumar, Y. Anil; Sirisha, Y.; Harini, A. L.; Prathyusha, A. – From World Journal of Pharmaceutical Research (2018), 7(8Spec.Iss.), 1-8

Request For Quotation